Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 411.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.18% |
| Dec 31, 2025 | 6.71% |
| Sep 30, 2025 | 18.29% |
| Jun 30, 2025 | -538.06% |
| Mar 31, 2025 | -560.87% |
| Dec 31, 2024 | 108.67% |
| Sep 30, 2024 | 50.21% |
| Jun 30, 2024 | 64.42% |
| Mar 31, 2024 | -121.10% |
| Dec 31, 2023 | 138.96% |
| Sep 30, 2023 | 851.61% |
| Jun 30, 2023 | 191.07% |
| Mar 31, 2023 | 3,533.33% |
| Dec 31, 2022 | -612.96% |
| Sep 30, 2022 | 63.95% |
| Jun 30, 2022 | 109.17% |
| Mar 31, 2022 | -98.61% |
| Dec 31, 2021 | -122.59% |
| Sep 30, 2021 | -132.21% |
| Jun 30, 2021 | -395.17% |
| Mar 31, 2021 | 176.60% |
| Dec 31, 2020 | 82.44% |
| Sep 30, 2020 | 48.33% |
| Jun 30, 2020 | -55.19% |
| Mar 31, 2020 | -289.26% |
| Dec 31, 2019 | -51.30% |
| Sep 30, 2019 | -27.13% |
| Jun 30, 2019 | 201.96% |
| Mar 31, 2019 | 93.51% |
| Dec 31, 2018 | -30.49% |
| Sep 30, 2018 | 133.02% |
| Jun 30, 2018 | -13.07% |
| Mar 31, 2018 | -46.53% |
| Dec 31, 2017 | 98.46% |
| Sep 30, 2017 | -28.86% |
| Jun 30, 2017 | -6.88% |
| Mar 31, 2017 | 16.13% |
| Dec 31, 2016 | 44.44% |
| Sep 30, 2016 | 4.20% |
| Jun 30, 2016 | 31.25% |
| Mar 31, 2016 | 6.90% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 232.56% |
| Jun 30, 2015 | 97.26% |
| Mar 31, 2015 | 173.42% |
| Dec 31, 2014 | 40.63% |
| Sep 30, 2014 | -66.92% |
| Jun 30, 2014 | 1.39% |
| Mar 31, 2014 | -313.51% |
| Dec 31, 2013 | -72.25% |
| Sep 30, 2013 | 124.14% |
| Jun 30, 2013 | 50.00% |
| Mar 31, 2013 | 45.10% |
| Dec 31, 2012 | 293.18% |
| Sep 30, 2012 | -24.68% |
| Jun 30, 2012 | -40.74% |
| Mar 31, 2012 | -5.56% |
| Dec 31, 2011 | 33.33% |
| Sep 30, 2011 | 0.00% |
| Jun 30, 2011 | 0.00% |